Showing results (131-140 of 147) with videos related to
Sort By:
Pageof 15
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 2, 2010
Pharmacokinetics of metformin during pregnancySara Eyal, Thomas R Easterling, Darcy Carr, et al.Pharmacogenetics and Genomics|September 5, 2008
Role of cytochrome P450 2C8 and 2J2 genotypes in calcineurin inhibitor-induced chronic kidney diseaseHelen E Smith, J P Jones, Thomas F Kalhorn, et al.American Journal of Obstetrics and Gynecology|February 26, 2023
Long-term neurodevelopmental follow-up of children exposed to pravastatin in uteroMaged M Costantine, Rebecca G Clifton, Trisha M Boekhoudt, et al.Physiological Genomics|February 21, 2025
Kidney cell response to acute cardiorenal and isolated kidney ischemia-reperfusion injuryKevin G Burfeind, Yoshio Funahashi, Xiao-Tong Su, et al.Molecular Pharmacology|December 30, 2011
An inducible cytochrome P450 3A4-dependent vitamin D catabolic pathwayZhican Wang, Yvonne S Lin, Xi Emily Zheng, et al.Cancer Chemotherapy and Pharmacology|February 18, 2014
Pharmacokinetics of doxorubicin in pregnant womenRachel J Ryu, Sara Eyal, Henry G Kaplan, et al.Journal of Clinical Pharmacology|October 14, 2015
Pharmacokinetics of metoprolol during pregnancy and lactationRachel J Ryu, Sara Eyal, Thomas R Easterling, et al.American Journal of Obstetrics and Gynecology|January 3, 2016
Safety and pharmacokinetics of pravastatin used for the prevention of preeclampsia in high-risk pregnant women: a pilot randomized controlled trialMaged M Costantine, Kirsten Cleary, Mary F Hebert, et al.Clinical and Translational Science|May 7, 2010
Pharmacotherapy and pregnancy: highlights from the Second International Conference for Individualized Pharmacotherapy in PregnancyDavid M Haas, Mary F Hebert, Offie P Soldin, et al.Journal of Clinical Pharmacology|May 8, 2018
Prednisone Pharmacokinetics During Pregnancy and LactationRachel J Ryu, Thomas R Easterling, Steve N Caritis, et al.Pageof 15